Patrick Michael Reagan
The University of Texas MD Anderson Cancer Center
1 paper in the Anchorcite directory, published in 2017, cited 6,172 times in total.
ORCID profileResearch topics
- T-cell and B-cell Immunology · 1 paper
- CAR-T cell therapy research · 1 paper
- Lymphoma Diagnosis and Treatment · 1 paper
Frequent co-authors
- Sattva Swarup Neelapu · 1 paper
- Frederick Lundry Locke · 1 paper
- Nancy L. Bartlett · 1 paper
- Lazaros J. Lekakis · 1 paper
- David Bernard Miklos · 1 paper
- Caron Alyce Jacobson · 1 paper
- Ira Braunschweig · 1 paper
- Olalekan O. Oluwole · 1 paper
Papers
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaNew England Journal of Medicine · 2017 · 6,172 citations
BACKGROUND: In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory large B-cell lymphoma after the failure of conventional therapy. METHODS: anti-CD19 CAR T cells per kilogram…
Metadata from OpenAlex (CC0).